Theravance Biopharma (TBPH) Net Margin Growth (1y) (2014 - 2026)
Theravance Biopharma (TBPH) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 447.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 673.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,097.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,208.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,636.00 |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | -23,778.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23,778.00 |
| Mar 31, 2026 | 6,016.00 |
| Dec 31, 2025 | 14,522.00 |
| Sep 30, 2025 | 9,336.00 |
| Jun 30, 2025 | 32,528.00 |
| Mar 31, 2025 | -782.00 |
| Dec 31, 2024 | -5,260.00 |
| Sep 30, 2024 | -1,825.00 |
| Jun 30, 2024 | -215.00 |
| Mar 31, 2024 | 12,777.00 |
| Dec 31, 2023 | -5,677.00 |
| Sep 30, 2023 | -750,295.00 |
| Jun 30, 2023 | -28,012.00 |
| Mar 31, 2023 | -32,636.00 |
| Dec 31, 2022 | -14,591.00 |
| Sep 30, 2022 | 728,977.00 |
| Jun 30, 2022 | 6,991.00 |
| Mar 31, 2022 | 7,038.00 |
| Dec 31, 2021 | 57,420.00 |
| Sep 30, 2021 | 55,952.00 |